• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

United Therapeutics Corporation - Common Stock (NQ:UTHR)

507.16 -7.48 (-1.45%)
Streaming Delayed Price Updated: 4:00 PM EST, Dec 26, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 185,786
Open 514.88
Bid (Size) 502.85 (40)
Ask (Size) 514.00 (200)
Prev. Close 514.64
Today's Range 505.04 - 515.00
52wk Range 266.98 - 519.99
Shares Outstanding 44,891,523
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Therapeutics Stocks Q3 In Review: Biogen (NASDAQ:BIIB) Vs Peers
December 21, 2025
As the Q3 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the therapeutics industry, including Biogen (NASDAQ:BIIB) and its peers. 
Via StockStory
Topics Artificial Intelligence
News headline image
Why a $27 Million Buy Signals New Confidence in Weatherford Stock ↗
December 09, 2025
One global services provider just landed a long list of new contracts — and a major fund has quietly built a sizable stake. 
Via The Motley Fool
Topics Regulatory Compliance

Performance

YTD
+40.8%
+40.8%
1 Month
+4.4%
+4.4%
3 Month
+19.5%
+19.5%
6 Month
+76.5%
+76.5%
1 Year
+41.8%
+41.8%

More News

Read More
News headline image
Signet Jewelers Gains New $25 Million Institutional Backer — Is the Stock a Buy? ↗
December 09, 2025
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Why a Value Fund Has a $29 Million Bet on Core Natural Resources Stock ↗
December 09, 2025
Via The Motley Fool
Topics Regulatory Compliance Supply Chain
News headline image
Is Kulicke and Soffa Stock a Buy Even as One Fund Dumps a $10 Million Stake? ↗
December 09, 2025
Via The Motley Fool
Topics Regulatory Compliance
News headline image
United Therapeutics Corp (NASDAQ:UTHR): A Value Investing Case Study ↗
December 05, 2025
Via Chartmill
News headline image
United Therapeutics Corp (NASDAQ:UTHR): A Caviar Cruise Quality Investment ↗
November 26, 2025
Via Chartmill
News headline image
2 Mooning Stocks on Our Buy List and 1 That Underwhelm
November 21, 2025
Via StockStory
News headline image
Here's How Much $100 Invested In United Therapeutics 15 Years Ago Would Be Worth Today ↗
November 19, 2025
Via Benzinga
News headline image
United Therapeutics Corp (NASDAQ:UTHR) Presents a Compelling Value Investment Case ↗
November 12, 2025
Via Chartmill
News headline image
3 Reasons Investors Love United Therapeutics (UTHR)
November 09, 2025
Via StockStory
News headline image
Is United Therapeutics Corp Gaining or Losing Market Support? ↗
November 07, 2025
Via Benzinga
News headline image
P/E Ratio Insights for United Therapeutics ↗
November 07, 2025
Via Benzinga
News headline image
My Top Vanguard Index ETF Pick for 2026 ↗
November 06, 2025
Via The Motley Fool
Topics ETFs Economy Stocks
News headline image
The 5 Most Interesting Analyst Questions From United Therapeutics’s Q3 Earnings Call
November 05, 2025
Via StockStory
Topics Earnings Intellectual Property
News headline image
If You Invested $100 In United Therapeutics Stock 5 Years Ago, You Would Have This Much Today ↗
November 04, 2025
Via Benzinga
News headline image
United Therapeutics Corporation to Present at Upcoming Investor Conferences
November 04, 2025
From United Therapeutics Corporation
Via Business Wire
News headline image
United Therapeutics Corporation Announces First Transplant in EXPAND Clinical Trial of UKidney in Patients With End-Stage Renal Disease
November 03, 2025
From United Therapeutics Corporation
Via Business Wire
News headline image
2 Safe-and-Steady Stocks with Impressive Fundamentals and 1 We Avoid
November 02, 2025
Via StockStory
News headline image
United Therapeutics Corp (NASDAQ:UTHR) Offers Affordable Growth with Strong Profitability ↗
October 31, 2025
Via Chartmill
News headline image
United Therapeutics (UTHR) Earnings Transcript ↗
October 30, 2025
Via The Motley Fool
Topics Earnings Intellectual Property
News headline image
Insmed Catapults While IBD 50's Argenx Creeps Higher On Bullish Reports ↗
October 30, 2025
Via Investor's Business Daily
News headline image
UTHR Q3 Deep Dive: Clinical Pipeline Advances and High-Dose Product Launches Drive Outlook
October 30, 2025
Via StockStory
News headline image
Why Is United Therapeutics (UTHR) Stock Soaring Today
October 29, 2025
Via StockStory
News headline image
S&P 500 Tops 6,900 Ahead Fed Rate Move, Gold Reclaims $4,000: What's Moving Markets Wednesday? ↗
October 29, 2025
Via Benzinga
Topics Economy Stocks

Frequently Asked Questions

Is United Therapeutics Corporation - Common Stock publicly traded?
Yes, United Therapeutics Corporation - Common Stock is publicly traded.
What exchange does United Therapeutics Corporation - Common Stock trade on?
United Therapeutics Corporation - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for United Therapeutics Corporation - Common Stock?
The ticker symbol for United Therapeutics Corporation - Common Stock is UTHR on the Nasdaq Stock Market
What is the current price of United Therapeutics Corporation - Common Stock?
The current price of United Therapeutics Corporation - Common Stock is 507.16
When was United Therapeutics Corporation - Common Stock last traded?
The last trade of United Therapeutics Corporation - Common Stock was at 12/26/25 04:00 PM ET
What is the market capitalization of United Therapeutics Corporation - Common Stock?
The market capitalization of United Therapeutics Corporation - Common Stock is 22.77B
How many shares of United Therapeutics Corporation - Common Stock are outstanding?
United Therapeutics Corporation - Common Stock has 23B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap